Company · CIK 0001393434 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
OCULAR THERAPEUTIX, INC · OCUL
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 31, 2026 SForm 4 → | Sep 2, 4:01 pm EDT | Donald NotmanChief Operating Officer | 1,099 | $10.24 | $11,254 | 366,529 | −0.30% | |
| Aug 25, 2026 GForm 4 → | Aug 26, 5:56 pm EDT | Pravin DugelSee Remarks, Director | 100,184 | — | — | 744,903 | — | 10b5-1 |
| Aug 24, 2026 SForm 4 → | Aug 26, 5:59 pm EDT | Peter KaiserChief Development Officer | 3,035 | $10.77 | $32,687 | 264,378 | −1.13% | 10b5-1 |
| Aug 24, 2026 SForm 4 → | Aug 26, 5:58 pm EDT | Sanjay NayakChief Strategy Officer | 1,897 | $10.78 | $20,450 | 326,898 | −0.58% | 10b5-1 |
| Aug 24, 2026 SForm 4 → | Aug 26, 5:57 pm EDT | Jeffrey S. HeierChief Scientific Officer | 3,296 | $10.78 | $35,531 | 318,326 | −1.02% | 10b5-1 |
| Aug 24, 2026 SForm 4 → | Aug 26, 5:56 pm EDT | Pravin DugelSee Remarks, Director | 21,649 | $10.77 | $233,160 | 2,525,429 | −0.85% | 10b5-1 |
| Jun 16, 2026 GForm 4 → | Jun 18, 4:01 pm EDT | Pravin DugelSee Remarks, Director | 100,184 | — | — | 50,092 | — | |
| Jun 10, 2026 AForm 4 → | Jun 12, 5:23 pm EDT | Charles M WardenDirector | 14,000 | — | — | 100,464 | — | |
| Jun 10, 2026 AForm 4 → | Jun 12, 5:22 pm EDT | Adrienne L GravesDirector | 14,000 | — | — | 64,000 | — | |
| Jun 10, 2026 AForm 4 → | Jun 12, 5:22 pm EDT | Jason Shand RobinsChief Financial Officer | 15,441 | — | — | 68,097 | — | |
| Jun 10, 2026 AForm 4 → | Jun 12, 5:21 pm EDT | Seung Suh HongDirector | 14,000 | — | — | 60,933 | — | |
| Jun 10, 2026 AForm 4 → | Jun 12, 5:20 pm EDT | Richard L Lindstrom M.D.Director | 14,000 | — | — | 260,933 | — | |
| Jun 10, 2026 AForm 4 → | Jun 12, 5:19 pm EDT | Merilee RainesDirector | 14,000 | — | — | 60,933 | — | |
| Jun 10, 2026 AForm 4 → | Jun 12, 5:19 pm EDT | Leslie J. WilliamsDirector | 14,000 | — | — | 65,433 | — | |
| Jun 3, 2026 SForm 4 → | Jun 5, 4:01 pm EDT | Nadia WaheedChief Medical Officer | 14,828 | $8.27 | $122,628 | 300,079 | −4.71% | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 10, 2026 AForm 4 → | Jun 12, 5:23 pm EDT | Charles M WardenDirector | 44,000 | — | — | 44,000 | — | |
| Jun 10, 2026 AForm 4 → | Jun 12, 5:22 pm EDT | Adrienne L GravesDirector | 44,000 | — | — | 44,000 | — | |
| Jun 10, 2026 AForm 4 → | Jun 12, 5:22 pm EDT | Jason Shand RobinsChief Financial Officer | 14,024 | — | — | 14,024 | — | |
| Jun 10, 2026 AForm 4 → | Jun 12, 5:21 pm EDT | Seung Suh HongDirector | 44,000 | — | — | 44,000 | — | |
| Jun 10, 2026 AForm 4 → | Jun 12, 5:20 pm EDT | Richard L Lindstrom M.D.Director | 44,000 | — | — | 44,000 | — | |
| Jun 10, 2026 AForm 4 → | Jun 12, 5:19 pm EDT | Merilee RainesDirector | 44,000 | — | — | 44,000 | — | |
| Jun 10, 2026 AForm 4 → | Jun 12, 5:19 pm EDT | Leslie J. WilliamsDirector | 44,000 | — | — | 44,000 | — |